Surveillance of Effectiveness/Safety of Artemether-lumefantrine in Patients With Malaria
| Status: | Completed |
|---|---|
| Conditions: | Infectious Disease |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 4/8/2017 |
| Start Date: | May 1, 2010 |
| End Date: | September 30, 2015 |
Surveillance for the Effectiveness and Safety of Artemether-lumefantrine in Pediatric and Adult Patients With Malaria
The purpose of this study is to describe the pediatric and adult patients (U.S. and foreign
residents) diagnosed with malaria and treated with artemether-lumefantrine with regard to
their demographics, including evaluation of their malaria immune status, treatment
effectiveness, prior and concomitant medication use, and the occurrence of adverse events in
association with artemether-lumefantrine treatment, based on the information collected in
the CDC Malaria Case Surveillance Report Form.
residents) diagnosed with malaria and treated with artemether-lumefantrine with regard to
their demographics, including evaluation of their malaria immune status, treatment
effectiveness, prior and concomitant medication use, and the occurrence of adverse events in
association with artemether-lumefantrine treatment, based on the information collected in
the CDC Malaria Case Surveillance Report Form.
Inclusion Criteria:
- Any male or female infant, child or adult patient diagnosed with malaria who received
artemether-lumefantrine and was reported to the CDC. Malaria may be clinically
suspected or confirmed (microscopically, and/or by polymerase chain reaction [PCR],
and/or rapid diagnostic test [RDT]).
Exclusion Criteria:
We found this trial at
1
site
Click here to add this to my saved trials
